TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
table of content
1.1 CAR T-Cell Therapy Product Introduction
1.2.1 Russian CAR T-Cell Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Axicabtagene Ciloleucel (Yescarta)
1.2.3 Tisagenlecleucel (Kymriah)
1.2.4 Ciltacabtagene Autoleucel (Carvykti)
1.2.5 Brexucabtagene Autoleucel (Tecartus)
1.2.6 Lisocabtagene Maraleucel (Breyanzi)
1.3.1 Russia CAR T-Cell Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Leukemia
1.3.3 Lymphoma
1.3.4 Multiple Myeloma
1.3.5 Others
1.4 Russia CAR T-Cell Therapy Sales Estimates and Forecasts 2019-2030
1.5 Russia CAR T-Cell Therapy Hydrocephalus Shunts Revenue Estimates and Forecasts 2019-2030
1.6 Study Objectives
1.7 Years Considered
2.1 Russia CAR T-Cell Therapy Sales by Manufacturers
2.1.1 Russia CAR T-Cell Therapy Sales by Manufacturers (2019-2024)
2.1.2 Russia CAR T-Cell Therapy Sales Market Share by Manufacturers (2019-2024)
2.1.3 Top Largest Manufacturers of CAR T-Cell Therapy in 2023 in Russia
2.2 Russia CAR T-Cell Therapy Revenue by Manufacturers
2.2.1 Russia CAR T-Cell Therapy Revenue by Manufacturers (2019-2024)
2.2.2 Russia CAR T-Cell Therapy Revenue Market Share by Manufacturers (2019-2024)
2.2.3 Russia Top Companies by CAR T-Cell Therapy Revenue in 2023
2.3 Russia CAR T-Cell Therapy Sales Price by Manufacturers (2019-2024)
2.4 Analysis of Competitive Landscape
2.4.1 Manufacturers Market Concentration Ratio (CR3 and HHI)
2.4.2 Russia CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
2.4.3 Russia CAR T-Cell Therapy Manufacturers Geographical Distribution
2.5 Mergers & Acquisitions, Expansion Plans
3.1 CAR T-Cell Therapy Market Size by Region: 2019-2030
3.1.1 Russia CAR T-Cell Therapy Sales by Region: 2019-2024
3.1.2 Russia CAR T-Cell Therapy Sales Forecast by Region (2025-2030)
3.1.3 Russia CAR T-Cell Therapy Revenue by Region: 2019-2024
3.1.4 Russia CAR T-Cell Therapy Revenue Forecast by Region (2025-2030)
4.1 Russia CAR T-Cell Therapy Sales by Type
4.1.1 Russia CAR T-Cell Therapy Historical Sales by Type (2019-2024)
4.1.2 Russia CAR T-Cell Therapy Forecasted Sales by Type (2025-2030)
4.1.3 Russia CAR T-Cell Therapy Sales Market Share by Type (2019-2030)
4.2 Russia CAR T-Cell Therapy Revenue by Type
4.2.1 Russia CAR T-Cell Therapy Historical Revenue by Type (2019-2024)
4.2.2 Russia CAR T-Cell Therapy Forecasted Revenue by Type (2025-2030)
4.2.3 Russia CAR T-Cell Therapy Revenue Market Share by Type (2019-2030)
4.3 Russia CAR T-Cell Therapy Price by Type
4.3.1 Russia CAR T-Cell Therapy Price by Type (2019-2024)
4.3.2 Russia CAR T-Cell Therapy Price Forecast by Type (2025-2030)
5.1 Russia CAR T-Cell Therapy Sales by Application
5.1.1 Russia CAR T-Cell Therapy Historical Sales by Application (2019-2024)
5.1.2 Russia CAR T-Cell Therapy Forecasted Sales by Application (2025-2030)
5.1.3 Russia CAR T-Cell Therapy Sales Market Share by Application (2019-2030)
5.2 Russia CAR T-Cell Therapy Revenue by Application
5.2.1 Russia CAR T-Cell Therapy Historical Revenue by Application (2019-2024)
5.2.2 Russia CAR T-Cell Therapy Forecasted Revenue by Application (2025-2030)
5.2.3 Russia CAR T-Cell Therapy Revenue Market Share by Application (2019-2030)
5.3 Russia CAR T-Cell Therapy Price by Application
5.3.1 Russia CAR T-Cell Therapy Price by Application (2019-2024)
5.3.2 Russia CAR T-Cell Therapy Price Forecast by Application (2025-2030)
6.1 Pharmstandard
6.1.1 Pharmstandard Corporation Information
6.1.2 Pharmstandard Overview
6.1.3 Pharmstandard in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.1.4 Pharmstandard CAR T-Cell Therapy Product Introduction
6.1.5 Pharmstandard Recent Developments
6.2 Biocad
6.2.1 Biocad Corporation Information
6.2.2 Biocad Overview
6.2.3 Biocad in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.2.4 Biocad CAR T-Cell Therapy Product Introduction
6.2.5 Biocad Recent Developments
6.3 R-Pharm
6.3.1 R-Pharm Corporation Information
6.3.2 R-Pharm Overview
6.3.3 R-Pharm in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.3.4 R-Pharm CAR T-Cell Therapy Product Introduction
6.3.5 R-Pharm Recent Developments
6.4 Generium
6.4.1 Generium Corporation Information
6.4.2 Generium Overview
6.4.3 Generium in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.4.4 Generium CAR T-Cell Therapy Product Introduction
6.4.5 Generium Recent Developments
6.5 OncoTartis
6.5.1 OncoTartis Corporation Information
6.5.2 OncoTartis Overview
6.5.3 OncoTartis in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.5.4 OncoTartis CAR T-Cell Therapy Product Introduction
6.5.5 OncoTartis Recent Developments
6.6 HemaCore
6.6.1 HemaCore Corporation Information
6.6.2 HemaCore Overview
6.6.3 HemaCore in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.6.4 HemaCore CAR T-Cell Therapy Product Introduction
6.6.5 HemaCore Recent Developments
6.7 Cell Therapies
6.7.1 Cell Therapies Corporation Information
6.7.2 Cell Therapies Overview
6.7.3 Cell Therapies in Russia: CAR T-Cell Therapy Sales, Price, Revenue and Gross Margin (2019-2024)
6.7.4 Cell Therapies CAR T-Cell Therapy Product Introduction
6.7.5 Cell Therapies Recent Developments
7.1 CAR T-Cell Therapy Industry Chain Analysis
7.2 CAR T-Cell Therapy Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CAR T-Cell Therapy Production Mode & Process
7.4 CAR T-Cell Therapy Sales and Marketing
7.4.1 CAR T-Cell Therapy Sales Channels
7.4.2 CAR T-Cell Therapy Distributors
7.5 CAR T-Cell Therapy Customers
8.1.1 CAR T-Cell Therapy Industry Trends
8.1.2 CAR T-Cell Therapy Market Drivers
8.1.3 CAR T-Cell Therapy Market Challenges
8.1.4 CAR T-Cell Therapy Market Restraints
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
